×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Sensei Biotherapeutics Inc. (SNSE) NASDAQ

$1.09 - (-)

Market Cap: $27.33M

As of 03/27/24 12:00 AM EDT. Market open.

(SNSE)

Sensei Biotherapeutics Inc. (SNSE)
NASDAQ

$1.09
- (-)

Market Cap: $27.33M

As of 03/27/24 12:00 AM EDT. Market open.

Add to Portfolio

sensei biotherapeutics is an innovator in the field of next-generation cancer immunotherapies. sensei has pioneered a proprietary immuno-oncology technology platform, called spirit, to aid the immune system in the detection and elimination of cancer. the presence of subtle differences in antigen expression between cancer and normal is key to this process the spirit platform overcomes disabled ... read more

sensei biotherapeutics is an innovator in the field of next-generation cancer immunotherapies. sensei has pioneered a proprietary immuno-oncology technology platform, called spirit, to aid the immune system in the detection and elimination of cancer. the presence of subtle differences in antigen expression between cancer and normal is key to this process the spirit platform overcomes disabled immune recognition caused by cancer. the immune system has evolved to protect its host from foreign pathogens, effectively distinguishing healthy ‘self’ tissues from ‘non-self’. cancer is a unique challenge to the immune system. it arises from ‘self’ making immune recognition challenging, yet it is known to be altered. immune recognition of the subtle differences between ‘self’ and ‘non-self’ is key to effective cancer immunotherapy. headquartered in gaithersburg, md, sensei has built a unique and proprietary approach in-house and in collaboration with key academic collaborators at brown universit read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
38
Address
.
PRICE CHART FOR SENSEI BIOTHERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$1.09
Days Range
$1.02 - $1.12
52 week range
$0.51 - $1.93
Volume
4,916
Avg. Volume (30 days)
91,826
Market Cap
$27.33M
Dividend Yield
-
P/E
-
Shares Outstanding
25,070,980
Open
-
Previous Close
$1.09
Days Range
$1.02 - $1.12
52 week range
$0.51 - $1.93
Volume
4,916
Avg. Volume (30 days)
91,826
Market Cap
$27.33M
Dividend Yield
-
P/E
-
Shares Outstanding
25,070,980
FINANCIAL STATEMENTS FOR SENSEI BIOTHERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SENSEI BIOTHERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
van der Horst EdwardCHIEF SCIENTIFIC OFFICERFeb 15, 2024 Option Exercise$0.792,8432,24656,070Feb 16, 2024, 06:37 PM
Celebi JohnPRESIDENT AND CEOFeb 15, 2024 Option Exercise$0.795,8914,654105,420Feb 16, 2024, 06:28 PM
Colgan ErinCHIEF FINANCIAL OFFICERFeb 15, 2024 Option Exercise$0.793,6272,86567,462Feb 16, 2024, 06:25 PM
Celebi JohnPresident and CEOSep 11, 2023 Buy$0.85500425111,311Sep 13, 2023, 08:43 AM
Gallagher Patrick StephenChief Business OfficerFeb 15, 2023 Option Exercise$1.509,38314,07534,130Sep 11, 2023, 05:34 PM
van der Horst EdwardChief Scientific OfficerFeb 15, 2023 Option Exercise$1.509,52514,28852,913Sep 11, 2023, 05:33 PM
Celebi JohnPresident and CEOFeb 15, 2023 Option Exercise$1.5020,49230,738110,811Sep 11, 2023, 05:33 PM
Colgan ErinChief Financial OfficerFeb 15, 2023 Option Exercise$1.5010,94316,41568,089Sep 11, 2023, 05:31 PM
Cambrian BioPharma Inc10% OwnerJul 31, 2023 Option Exercise$1.261,587,3022,000,0013,653,120Aug 02, 2023, 05:09 PM
Peyer JamesDirectorJul 31, 2023 Option Exercise$1.261,587,3022,000,0013,653,120Aug 02, 2023, 05:06 PM
Apeiron Investment Group Ltd.10% OwnerJun 01, 2023 Sale$1.582,485,9233,927,7580Jun 02, 2023, 05:03 PM
Apeiron Investment Group Ltd.10% OwnerJun 01, 2023 Sale$1.58955,7381,510,0660Jun 02, 2023, 05:03 PM
Apeiron Investment Group Ltd.10% OwnerFeb 23, 2023 Buy$1.612,2003,5392,485,923Feb 27, 2023, 08:10 PM
Peyer JamesDirectorMar 02, 2022 Buy$3.201,2033,8505,231,488Jun 10, 2022, 02:18 PM
Cambrian BioPharma Inc10% OwnerMar 02, 2022 Buy$3.201,2033,8505,231,488Jun 10, 2022, 02:17 PM
Peyer JamesDirectorMar 23, 2021 Buy$14.349,500136,2304,798,293Apr 21, 2022, 04:25 PM
Peyer JamesDirectorFeb 18, 2021 Buy$19.7575214,8524,690,905Apr 21, 2022, 04:22 PM
Cambrian BioPharma Inc10% OwnerMar 23, 2021 Buy$14.349,500136,2304,798,293Apr 21, 2022, 04:19 PM
Cambrian BioPharma Inc10% OwnerFeb 18, 2021 Buy$19.7575214,8524,690,905Apr 21, 2022, 04:17 PM
Cambrian BioPharma Inc10% OwnerMar 02, 2022 Buy$3.201,2033,8505,231,989Mar 02, 2022, 01:42 PM
Peyer JamesDirectorMar 02, 2022 Buy$3.201,2033,8505,231,989Mar 02, 2022, 01:40 PM
Peyer JamesDirectorFeb 28, 2022 Buy$3.60421515,228,328Mar 01, 2022, 06:55 PM
Peyer JamesDirectorMar 01, 2022 Buy$3.602,4588,8495,230,786Mar 01, 2022, 06:55 PM
Cambrian BioPharma Inc10% OwnerMar 01, 2022 Buy$3.602,4588,8495,230,786Mar 01, 2022, 06:53 PM
Cambrian BioPharma Inc10% OwnerFeb 28, 2022 Buy$3.60421515,228,328Mar 01, 2022, 06:53 PM
Peyer JamesDirectorFeb 25, 2022 Buy$3.652,5009,1255,228,286Feb 28, 2022, 04:53 PM
Cambrian BioPharma Inc10% OwnerFeb 25, 2022 Buy$3.652,5009,1255,228,286Feb 28, 2022, 04:50 PM
Cambrian BioPharma Inc10% OwnerFeb 24, 2022 Buy$3.6315,00054,4505,225,786Feb 24, 2022, 07:15 PM
Cambrian BioPharma Inc10% OwnerFeb 23, 2022 Buy$3.802,5009,5005,210,786Feb 24, 2022, 07:15 PM
Peyer JamesDirectorFeb 24, 2022 Buy$3.6315,00054,4505,225,786Feb 24, 2022, 07:12 PM
Peyer JamesDirectorFeb 23, 2022 Buy$3.802,5009,5005,210,786Feb 24, 2022, 07:12 PM
Peyer JamesDirectorFeb 18, 2022 Buy$3.9715,00059,5505,208,286Feb 22, 2022, 11:36 AM
Peyer JamesDirectorFeb 17, 2022 Buy$4.174,94920,6375,193,286Feb 22, 2022, 11:36 AM
Cambrian BioPharma Inc10% OwnerFeb 18, 2022 Buy$3.9715,00059,5505,208,286Feb 22, 2022, 11:35 AM
Cambrian BioPharma Inc10% OwnerFeb 17, 2022 Buy$4.174,94920,6375,193,286Feb 22, 2022, 11:35 AM
Cambrian BioPharma Inc10% OwnerFeb 16, 2022 Buy$4.252,55110,8425,188,337Feb 16, 2022, 06:59 PM
Cambrian BioPharma Inc10% OwnerFeb 14, 2022 Buy$4.1810,00041,8005,185,786Feb 16, 2022, 06:59 PM
Peyer JamesDirectorFeb 16, 2022 Buy$4.252,55110,8425,188,337Feb 16, 2022, 06:54 PM
Peyer JamesDirectorFeb 14, 2022 Buy$4.1810,00041,8005,185,786Feb 16, 2022, 06:54 PM
Peyer JamesDirectorFeb 11, 2022 Buy$4.4012,50055,0005,175,786Feb 14, 2022, 07:19 PM
Peyer JamesDirectorFeb 10, 2022 Buy$4.585,00022,9005,163,286Feb 14, 2022, 07:19 PM
Cambrian BioPharma Inc10% OwnerFeb 11, 2022 Buy$4.4012,50055,0005,175,786Feb 14, 2022, 07:18 PM
Cambrian BioPharma Inc10% OwnerFeb 10, 2022 Buy$4.585,00022,9005,163,286Feb 14, 2022, 07:18 PM
Cambrian BioPharma Inc10% OwnerFeb 04, 2022 Buy$4.452,50011,1255,148,286Feb 08, 2022, 06:42 PM
Cambrian BioPharma Inc10% OwnerFeb 03, 2022 Buy$4.6517,50081,3755,145,786Feb 08, 2022, 06:42 PM
Cambrian BioPharma Inc10% OwnerFeb 08, 2022 Buy$4.3310,00043,3005,158,286Feb 08, 2022, 06:42 PM
Peyer JamesDirectorFeb 08, 2022 Buy$4.3310,00043,3005,158,286Feb 08, 2022, 06:40 PM
Peyer JamesDirectorFeb 04, 2022 Buy$4.452,50011,1255,148,286Feb 08, 2022, 06:40 PM
Peyer JamesDirectorFeb 03, 2022 Buy$4.6517,50081,3755,145,786Feb 08, 2022, 06:40 PM
Cambrian BioPharma Inc10% OwnerJan 27, 2022 Buy$4.316,10026,2915,119,386Jan 31, 2022, 11:30 AM
Cambrian BioPharma Inc10% OwnerJan 28, 2022 Buy$4.228,90037,5585,128,286Jan 31, 2022, 11:30 AM
Peyer JamesDirectorJan 28, 2022 Buy$4.228,90037,5585,128,286Jan 31, 2022, 11:26 AM
Peyer JamesDirectorJan 27, 2022 Buy$4.316,10026,2915,119,386Jan 31, 2022, 11:26 AM
Peyer JamesDirectorJan 26, 2022 Buy$4.6229,900138,1385,113,286Jan 27, 2022, 10:31 AM
Peyer JamesDirectorJan 25, 2022 Buy$4.8620,10097,6865,083,386Jan 27, 2022, 10:31 AM
Cambrian BioPharma Inc10% OwnerJan 25, 2022 Buy$4.8620,10097,6865,083,386Jan 27, 2022, 10:26 AM
Cambrian BioPharma Inc10% OwnerJan 26, 2022 Buy$4.6229,900138,1385,113,286Jan 27, 2022, 10:26 AM
Peyer JamesDirectorJan 24, 2022 Buy$4.6922,707106,4965,063,286Jan 25, 2022, 09:14 AM
Peyer JamesDirectorJan 21, 2022 Buy$4.9424,703122,0335,040,579Jan 25, 2022, 09:14 AM
Cambrian BioPharma Inc10% OwnerJan 24, 2022 Buy$4.6922,707106,4965,063,286Jan 25, 2022, 09:12 AM
Cambrian BioPharma Inc10% OwnerJan 21, 2022 Buy$4.9424,703122,0335,040,579Jan 25, 2022, 09:12 AM
Peyer JamesDirectorJan 20, 2022 Buy$5.1720,000103,4005,015,876Jan 21, 2022, 06:20 PM
Peyer JamesDirectorJan 19, 2022 Buy$4.9710,24450,9134,995,876Jan 21, 2022, 06:20 PM
Cambrian BioPharma Inc10% OwnerJan 20, 2022 Buy$5.1720,000103,4005,015,876Jan 21, 2022, 06:16 PM
Cambrian BioPharma Inc10% OwnerJan 19, 2022 Buy$4.9710,24450,9134,995,876Jan 21, 2022, 06:16 PM
Peyer JamesDirectorJan 18, 2022 Buy$5.0810,00050,8004,985,632Jan 20, 2022, 09:07 AM
Cambrian BioPharma Inc10% OwnerJan 18, 2022 Buy$5.0810,00050,8004,985,632Jan 20, 2022, 09:05 AM
Peyer JamesDirectorJan 14, 2022 Buy$4.996,21931,0334,975,632Jan 18, 2022, 10:20 AM
Peyer JamesDirectorJan 13, 2022 Buy$5.1319,953102,3594,969,413Jan 18, 2022, 10:20 AM
Cambrian BioPharma Inc10% OwnerJan 14, 2022 Buy$4.996,21931,0334,975,632Jan 18, 2022, 10:17 AM
Cambrian BioPharma Inc10% OwnerJan 13, 2022 Buy$5.1319,953102,3594,969,413Jan 18, 2022, 10:17 AM
Peyer JamesDirectorJan 12, 2022 Buy$5.229,20248,0344,949,460Jan 13, 2022, 04:14 PM
Peyer JamesDirectorJan 11, 2022 Buy$5.1810,84556,1774,940,258Jan 13, 2022, 04:14 PM
Cambrian BioPharma Inc10% OwnerJan 12, 2022 Buy$5.229,20248,0344,949,460Jan 13, 2022, 04:13 PM
Cambrian BioPharma Inc10% OwnerJan 11, 2022 Buy$5.1810,84556,1774,940,258Jan 13, 2022, 04:13 PM
Peyer JamesDirectorJan 10, 2022 Buy$5.2810,00052,8004,929,413Jan 11, 2022, 03:29 PM
Cambrian BioPharma Inc10% OwnerJan 10, 2022 Buy$5.2810,00052,8004,929,413Jan 11, 2022, 03:22 PM
Peyer JamesDirectorDec 30, 2021 Buy$4.851,1275,4664,919,413Jan 03, 2022, 09:40 AM
Cambrian BioPharma Inc10% OwnerDec 30, 2021 Buy$4.851,1275,4664,919,413Jan 03, 2022, 09:38 AM
Peyer JamesDirectorDec 29, 2021 Buy$4.9869,000343,6204,918,286Dec 30, 2021, 12:25 PM
Cambrian BioPharma Inc10% OwnerDec 29, 2021 Buy$4.9869,000343,6204,918,286Dec 30, 2021, 12:24 PM
Peyer JamesDirectorDec 28, 2021 Buy$5.2811,28859,6014,849,286Dec 29, 2021, 12:04 PM
Cambrian BioPharma Inc10% OwnerDec 28, 2021 Buy$5.2811,28859,6014,849,286Dec 29, 2021, 11:37 AM
Peyer JamesDirectorDec 27, 2021 Buy$5.303,71219,6744,837,998Dec 27, 2021, 06:08 PM
Cambrian BioPharma Inc10% OwnerDec 27, 2021 Buy$5.303,71219,6744,837,998Dec 27, 2021, 06:04 PM
Peyer JamesDirectorDec 23, 2021 Buy$5.2711,00057,9704,834,286Dec 23, 2021, 06:55 PM
Cambrian BioPharma Inc10% OwnerDec 23, 2021 Buy$5.2711,00057,9704,834,286Dec 23, 2021, 06:53 PM
Peyer JamesDirectorDec 17, 2021 Buy$5.291176194,823,286Dec 21, 2021, 03:54 PM
Cambrian BioPharma Inc10% OwnerDec 17, 2021 Buy$5.291176194,823,286Dec 21, 2021, 03:48 PM
Cambrian BioPharma Inc10% OwnerDec 16, 2021 Buy$5.2510,92557,3564,823,169Dec 20, 2021, 05:23 PM
Peyer JamesDirectorDec 16, 2021 Buy$5.2510,92557,3564,823,169Dec 20, 2021, 05:18 PM
RICKS THOMAS GDirectorDec 10, 2021 Buy$5.8620,000117,200341,769Dec 13, 2021, 04:15 PM
RICKS THOMAS GDirectorDec 09, 2021 Buy$6.6220,000132,400321,769Dec 13, 2021, 04:15 PM
Pierce Robert HamiltonChief Scientific OfficerAug 11, 2021 Sale$7.3416,030117,7180Aug 12, 2021, 05:07 PM
Pierce Robert HamiltonChief Scientific OfficerAug 06, 2021 Sale$7.116,46045,94889,362Aug 10, 2021, 05:40 PM
Pierce Robert HamiltonChief Scientific OfficerAug 10, 2021 Sale$7.1366,350473,00316,030Aug 10, 2021, 05:40 PM
Pierce Robert HamiltonChief Scientific OfficerAug 09, 2021 Sale$7.066,98249,29582,380Aug 10, 2021, 05:40 PM
Peyer JamesDirectorMay 05, 2021 Buy$12.003504,2004,812,244May 06, 2021, 04:34 PM
Cambrian BioPharma Inc10% OwnerApr 20, 2021 Buy$12.773854,9164,811,894Apr 21, 2021, 03:52 PM
Peyer JamesDirectorApr 19, 2021 Buy$13.381,96526,2924,811,509Apr 20, 2021, 03:37 PM
Cambrian BioPharma Inc10% OwnerApr 19, 2021 Buy$13.381,96526,2924,811,509Apr 20, 2021, 03:31 PM
Cambrian BioPharma Inc10% OwnerApr 13, 2021 Buy$14.002,00028,0004,809,544Apr 14, 2021, 05:00 PM
Peyer JamesDirectorApr 13, 2021 Buy$14.002,00028,0004,809,544Apr 14, 2021, 04:41 PM
Peyer JamesDirectorApr 07, 2021 Buy$14.002,00028,0004,807,544Apr 08, 2021, 06:13 PM
Cambrian BioPharma Inc10% OwnerApr 01, 2021 Buy$14.001,00014,0004,805,544Apr 02, 2021, 02:58 PM
Peyer JamesDirectorApr 01, 2021 Buy$14.001,00014,0004,805,544Apr 02, 2021, 02:56 PM
Cambrian BioPharma Inc10% OwnerMar 30, 2021 Buy$12.002,00024,0004,804,544Mar 31, 2021, 03:43 PM
Peyer JamesDirectorMar 30, 2021 Buy$12.002,00024,0004,804,544Mar 31, 2021, 03:41 PM
Peyer JamesDirectorMar 24, 2021 Buy$14.123,75052,9504,802,544Mar 25, 2021, 12:40 PM
Cambrian BioPharma Inc10% OwnerMar 24, 2021 Buy$14.123,75052,9504,802,544Mar 25, 2021, 12:37 PM
Peyer JamesDirectorMar 23, 2021 Buy$14.3410,000143,4004,798,794Mar 24, 2021, 04:21 PM
Cambrian BioPharma Inc10% OwnerMar 23, 2021 Buy$14.3410,000143,4004,798,794Mar 24, 2021, 04:19 PM
Cambrian BioPharma Inc10% OwnerMar 22, 2021 Buy$15.022,18332,7894,788,794Mar 23, 2021, 12:34 PM
Peyer JamesDirectorMar 22, 2021 Buy$15.022,18332,7894,788,794Mar 23, 2021, 12:32 PM
Cambrian BioPharma Inc10% OwnerMar 18, 2021 Buy$15.2581712,4594,786,611Mar 19, 2021, 03:51 PM
Peyer JamesDirectorMar 18, 2021 Buy$15.2581712,4594,786,611Mar 19, 2021, 03:44 PM
Peyer JamesDirectorMar 08, 2021 Buy$15.251,00015,2494,785,794Mar 10, 2021, 05:37 PM
Cambrian BioPharma Inc10% OwnerMar 08, 2021 Buy$15.251,00015,2494,785,794Mar 10, 2021, 05:35 PM
Cambrian BioPharma Inc10% OwnerMar 05, 2021 Buy$13.758,000110,0004,784,794Mar 08, 2021, 04:55 PM
Peyer JamesDirectorMar 05, 2021 Buy$13.758,000110,0004,784,794Mar 08, 2021, 04:48 PM
Cambrian BioPharma Inc10% OwnerMar 03, 2021 Buy$15.853,00047,5504,774,794Mar 05, 2021, 01:57 PM
Cambrian BioPharma Inc10% OwnerMar 04, 2021 Buy$14.132,00028,2504,776,794Mar 05, 2021, 01:57 PM
Peyer JamesDirectorMar 04, 2021 Buy$14.132,00028,2504,776,794Mar 05, 2021, 01:55 PM
Peyer JamesDirectorMar 03, 2021 Buy$15.853,00047,5504,774,794Mar 05, 2021, 01:55 PM
Peyer JamesDirectorMar 02, 2021 Buy$16.253,00048,7504,771,794Mar 03, 2021, 05:22 PM
Cambrian BioPharma Inc10% OwnerMar 02, 2021 Buy$16.253,00048,7504,771,794Mar 03, 2021, 12:00 AM
Peyer JamesDirectorFeb 26, 2021 Buy$16.255,00081,2504,768,794Mar 02, 2021, 04:15 PM
Cambrian BioPharma Inc10% OwnerFeb 26, 2021 Buy$16.255,00081,2504,768,794Mar 02, 2021, 04:15 PM
Peyer JamesDirectorFeb 25, 2021 Buy$15.7912,000189,4804,763,794Feb 26, 2021, 04:05 PM
Peyer JamesDirectorFeb 24, 2021 Buy$16.9119,000321,3824,751,794Feb 26, 2021, 04:05 PM
Cambrian BioPharma Inc10% OwnerFeb 25, 2021 Buy$15.7912,000189,4804,763,794Feb 26, 2021, 04:05 PM
Cambrian BioPharma Inc10% OwnerFeb 24, 2021 Buy$16.9119,000321,3824,751,794Feb 26, 2021, 04:05 PM
Peyer JamesDirectorFeb 23, 2021 Buy$17.7920,300361,0704,732,794Feb 25, 2021, 05:55 PM
Cambrian BioPharma Inc10% OwnerFeb 23, 2021 Buy$17.7920,300361,0704,732,794Feb 25, 2021, 05:55 PM
Cambrian BioPharma Inc10% OwnerFeb 22, 2021 Buy$18.889,802185,0624,712,494Feb 24, 2021, 08:32 PM
Peyer JamesDirectorFeb 22, 2021 Buy$18.889,802185,0624,712,494Feb 24, 2021, 08:27 PM
Peyer JamesDirectorFeb 19, 2021 Buy$19.7711,786233,0094,702,692Feb 23, 2021, 04:15 PM
Cambrian BioPharma Inc10% OwnerFeb 19, 2021 Buy$19.7711,786233,0094,702,692Feb 23, 2021, 04:15 PM
Peyer JamesDirectorFeb 18, 2021 Buy$19.7575314,8724,690,906Feb 19, 2021, 04:15 PM
Cambrian BioPharma Inc10% OwnerFeb 18, 2021 Buy$19.7575314,8724,690,906Feb 19, 2021, 04:15 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
van der Horst EdwardCHIEF SCIENTIFIC OFFICER02/15/20242,246
Celebi JohnPRESIDENT AND CEO02/15/20244,654
Colgan ErinCHIEF FINANCIAL OFFICER02/15/20242,865
Celebi JohnPresident and CEO09/11/2023425
Gallagher Patrick StephenChief Business Officer02/15/202314,075
van der Horst EdwardChief Scientific Officer02/15/202314,288
Celebi JohnPresident and CEO02/15/202330,738
Colgan ErinChief Financial Officer02/15/202316,415
Cambrian BioPharma Inc10% Owner07/31/20232,000,001
Peyer JamesDirector07/31/20232,000,001
Apeiron Investment Group Ltd.10% Owner06/01/20233,927,758
Apeiron Investment Group Ltd.10% Owner06/01/20231,510,066
Apeiron Investment Group Ltd.10% Owner02/23/20233,539
Peyer JamesDirector03/02/20223,850
Cambrian BioPharma Inc10% Owner03/02/20223,850
Peyer JamesDirector03/23/2021136,230
Peyer JamesDirector02/18/202114,852
Cambrian BioPharma Inc10% Owner03/23/2021136,230
Cambrian BioPharma Inc10% Owner02/18/202114,852
Cambrian BioPharma Inc10% Owner03/02/20223,850
Peyer JamesDirector03/02/20223,850
Peyer JamesDirector02/28/2022151
Peyer JamesDirector03/01/20228,849
Cambrian BioPharma Inc10% Owner03/01/20228,849
Cambrian BioPharma Inc10% Owner02/28/2022151
Peyer JamesDirector02/25/20229,125
Cambrian BioPharma Inc10% Owner02/25/20229,125
Cambrian BioPharma Inc10% Owner02/24/202254,450
Cambrian BioPharma Inc10% Owner02/23/20229,500
Peyer JamesDirector02/24/202254,450
Peyer JamesDirector02/23/20229,500
Peyer JamesDirector02/18/202259,550
Peyer JamesDirector02/17/202220,637
Cambrian BioPharma Inc10% Owner02/18/202259,550
Cambrian BioPharma Inc10% Owner02/17/202220,637
Cambrian BioPharma Inc10% Owner02/16/202210,842
Cambrian BioPharma Inc10% Owner02/14/202241,800
Peyer JamesDirector02/16/202210,842
Peyer JamesDirector02/14/202241,800
Peyer JamesDirector02/11/202255,000
Peyer JamesDirector02/10/202222,900
Cambrian BioPharma Inc10% Owner02/11/202255,000
Cambrian BioPharma Inc10% Owner02/10/202222,900
Cambrian BioPharma Inc10% Owner02/04/202211,125
Cambrian BioPharma Inc10% Owner02/03/202281,375
Cambrian BioPharma Inc10% Owner02/08/202243,300
Peyer JamesDirector02/08/202243,300
Peyer JamesDirector02/04/202211,125
Peyer JamesDirector02/03/202281,375
Cambrian BioPharma Inc10% Owner01/27/202226,291
Cambrian BioPharma Inc10% Owner01/28/202237,558
Peyer JamesDirector01/28/202237,558
Peyer JamesDirector01/27/202226,291
Peyer JamesDirector01/26/2022138,138
Peyer JamesDirector01/25/202297,686
Cambrian BioPharma Inc10% Owner01/25/202297,686
Cambrian BioPharma Inc10% Owner01/26/2022138,138
Peyer JamesDirector01/24/2022106,496
Peyer JamesDirector01/21/2022122,033
Cambrian BioPharma Inc10% Owner01/24/2022106,496
Cambrian BioPharma Inc10% Owner01/21/2022122,033
Peyer JamesDirector01/20/2022103,400
Peyer JamesDirector01/19/202250,913
Cambrian BioPharma Inc10% Owner01/20/2022103,400
Cambrian BioPharma Inc10% Owner01/19/202250,913
Peyer JamesDirector01/18/202250,800
Cambrian BioPharma Inc10% Owner01/18/202250,800
Peyer JamesDirector01/14/202231,033
Peyer JamesDirector01/13/2022102,359
Cambrian BioPharma Inc10% Owner01/14/202231,033
Cambrian BioPharma Inc10% Owner01/13/2022102,359
Peyer JamesDirector01/12/202248,034
Peyer JamesDirector01/11/202256,177
Cambrian BioPharma Inc10% Owner01/12/202248,034
Cambrian BioPharma Inc10% Owner01/11/202256,177
Peyer JamesDirector01/10/202252,800
Cambrian BioPharma Inc10% Owner01/10/202252,800
Peyer JamesDirector12/30/20215,466
Cambrian BioPharma Inc10% Owner12/30/20215,466
Peyer JamesDirector12/29/2021343,620
Cambrian BioPharma Inc10% Owner12/29/2021343,620
Peyer JamesDirector12/28/202159,601
Cambrian BioPharma Inc10% Owner12/28/202159,601
Peyer JamesDirector12/27/202119,674
Cambrian BioPharma Inc10% Owner12/27/202119,674
Peyer JamesDirector12/23/202157,970
Cambrian BioPharma Inc10% Owner12/23/202157,970
Peyer JamesDirector12/17/2021619
Cambrian BioPharma Inc10% Owner12/17/2021619
Cambrian BioPharma Inc10% Owner12/16/202157,356
Peyer JamesDirector12/16/202157,356
RICKS THOMAS GDirector12/10/2021117,200
RICKS THOMAS GDirector12/09/2021132,400
Pierce Robert HamiltonChief Scientific Officer08/11/2021117,718
Pierce Robert HamiltonChief Scientific Officer08/06/202145,948
Pierce Robert HamiltonChief Scientific Officer08/10/2021473,003
Pierce Robert HamiltonChief Scientific Officer08/09/202149,295
Peyer JamesDirector05/05/20214,200
Cambrian BioPharma Inc10% Owner04/20/20214,916
Peyer JamesDirector04/19/202126,292
Cambrian BioPharma Inc10% Owner04/19/202126,292
Cambrian BioPharma Inc10% Owner04/13/202128,000
Peyer JamesDirector04/13/202128,000
Peyer JamesDirector04/07/202128,000
Cambrian BioPharma Inc10% Owner04/01/202114,000
Peyer JamesDirector04/01/202114,000
Cambrian BioPharma Inc10% Owner03/30/202124,000
Peyer JamesDirector03/30/202124,000
Peyer JamesDirector03/24/202152,950
Cambrian BioPharma Inc10% Owner03/24/202152,950
Peyer JamesDirector03/23/2021143,400
Cambrian BioPharma Inc10% Owner03/23/2021143,400
Cambrian BioPharma Inc10% Owner03/22/202132,789
Peyer JamesDirector03/22/202132,789
Cambrian BioPharma Inc10% Owner03/18/202112,459
Peyer JamesDirector03/18/202112,459
Peyer JamesDirector03/08/202115,249
Cambrian BioPharma Inc10% Owner03/08/202115,249
Cambrian BioPharma Inc10% Owner03/05/2021110,000
Peyer JamesDirector03/05/2021110,000
Cambrian BioPharma Inc10% Owner03/03/202147,550
Cambrian BioPharma Inc10% Owner03/04/202128,250
Peyer JamesDirector03/04/202128,250
Peyer JamesDirector03/03/202147,550
Peyer JamesDirector03/02/202148,750
Cambrian BioPharma Inc10% Owner03/02/202148,750
Peyer JamesDirector02/26/202181,250
Cambrian BioPharma Inc10% Owner02/26/202181,250
Peyer JamesDirector02/25/2021189,480
Peyer JamesDirector02/24/2021321,382
Cambrian BioPharma Inc10% Owner02/25/2021189,480
Cambrian BioPharma Inc10% Owner02/24/2021321,382
Peyer JamesDirector02/23/2021361,070
Cambrian BioPharma Inc10% Owner02/23/2021361,070
Cambrian BioPharma Inc10% Owner02/22/2021185,062
Peyer JamesDirector02/22/2021185,062
Peyer JamesDirector02/19/2021233,009
Cambrian BioPharma Inc10% Owner02/19/2021233,009
Peyer JamesDirector02/18/202114,872
Cambrian BioPharma Inc10% Owner02/18/202114,872
Load More Insider Transactions
FUNDS WITH A POSITION IN SENSEI BIOTHERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC143,5080.00015%71.25%Other
GEODE CAPITAL MANAGEMENT, LLC136,3180.00001%No changeOther
DUQUESNE FAMILY OFFICE LLC100,0000.00206%No changeOther
BLACKROCK INC.34,8130%-1.17%Other
CHANGE IN SHARES OUTSTANDING FOR SENSEI BIOTHERAPEUTICS INC
STOCK BUYBACKS FOR SENSEI BIOTHERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
-16.37%
1Q
09/30/2023
03/31/2023
-17.34%
2Q
09/30/2023
12/31/2022
-17.01%
3Q
09/30/2023
09/30/2022
-16.95%
4Q
09/30/2023
06/30/2022
-16.90%
5Q
09/30/2023
03/31/2022
-16.75%
6Q
09/30/2023
12/31/2021
-16.71%
7Q
09/30/2023
09/30/2021
-16.59%
8Q
09/30/2023
06/30/2021
-16.59%
9Q
09/30/2023
03/31/2021
34.96%
10Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
-16.37%
1Q
03/31/2023
-17.34%
2Q
12/31/2022
-17.01%
3Q
09/30/2022
-16.95%
4Q
06/30/2022
-16.90%
5Q
03/31/2022
-16.75%
6Q
12/31/2021
-16.71%
7Q
09/30/2021
-16.59%
8Q
06/30/2021
-16.59%
9Q
03/31/2021
34.96%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SENSEI BIOTHERAPEUTICS INC
LOADING...